.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The SENOMAC randomized clinical trial evaluated whether completion axillary lymph-node dissection could be omitted in women with breast cancer who had limited sentinel-node metastases. The study found very similar recurrence-free outcomes between patients who underwent axillary dissection and those managed without it, supporting a less invasive approach for appropriately selected patients. The clinical significance is substantial because axillary dissection can cause long-term morbidity, including lymphedema, pain and shoulder dysfunction. For breast surgeons, the message is that the presence of limited sentinel-node disease does not automatically mandate a more extensive axillary operation. Patient selection and the broader treatment context remain crucial, including tumor biology, systemic therapy, radiotherapy and the extent of nodal disease. The trial strengthens the move toward de-escalation of surgery where equivalent cancer control can be maintained. It also reinforces the role of multidisciplinary breast teams in integrating surgical, radiation and systemic treatment decisions rather than making the axillary procedure in isolation.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The SENOMAC randomized clinical trial evaluated whether completion axillary lymph-node dissection could be omitted in women with breast cancer who had limited sentinel-node metastases. The study found very similar recurrence-free outcomes between patients who underwent axillary dissection and those managed without it, supporting a less invasive approach for appropriately selected patients. The clinical significance is substantial because axillary dissection can cause long-term morbidity, including lymphedema, pain and shoulder dysfunction. For breast surgeons, the message is that the presence of limited sentinel-node disease does not automatically mandate a more extensive axillary operation. Patient selection and the broader treatment context remain crucial, including tumor biology, systemic therapy, radiotherapy and the extent of nodal disease. The trial strengthens the move toward de-escalation of surgery where equivalent cancer control can be maintained. It also reinforces the role of multidisciplinary breast teams in integrating surgical, radiation and systemic treatment decisions rather than making the axillary procedure in isolation.
4 weeks back
A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
4 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
5 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back
